|
DCTH
|
Delcath Systems, Inc.
|
US
|
NASDAQ
|
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
FENC
|
Fennec Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GH
|
Guardant Health, Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
US
|
NASDAQ
|
|
GTH
|
Genetron Holdings Limited
|
US
|
NASDAQ
|
|
HARP
|
Harpoon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HRTX
|
Heron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ICUI
|
ICU Medical, Inc.
|
US
|
NASDAQ
|
|
IKNA
|
Ikena Oncology, Inc.
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
US
|
NASDAQ
|
|
IMRX
|
Immuneering Corporation
|
US
|
NASDAQ
|
|
IMV
|
IMV Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
ISR
|
IsoRay, Inc.
|
US
|
AMEX
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
US
|
NASDAQ
|
|
MBRX
|
Moleculin Biotech, Inc.
|
US
|
NASDAQ
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|